AJ Joshi

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About AJ Joshi

Atara Biotherapeutics, Inc. reported in an 8-K filed January 8, 2024 that AJ Joshi was terminated as Executive Vice President, Chief Medical Officer, effective February 2, 2024.

“On January 8, 2024, the Company announced that the employment of Manher (AJ) Joshi, the Company's Executive Vice President, Chief Medical Officer, would terminate effective as of February 2, 2024.”

Atara Biotherapeutics, Inc. Form 8-K, filed January 8, 2024 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Research with Equibles

Turn this profile into a cited research brief

Start with a question tailored to the filings and events on this page, or connect Equibles financial data to ChatGPT or Claude.

Suggested question: “Summarize AJ Joshi's recent executive appointments or departures and cite the source filings.”

Use in your AI

Affiliation history

Recorded current and former roles; source labels appear when available.

Atara Biotherapeutics, Inc. (ATRA)
Source not stated

Start not stated–2024-02-02

Company network

Recorded roles and call appearances connecting this person to public companies.

Atara Biotherapeutics, Inc.

ATRA

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.

Executive change Terminated: Executive Vice President, Chief Medical Officer Atara Biotherapeutics, Inc. (ATRA)
2024-02-02